✦ LIBER ✦

High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia

✍ Scribed by Wei Xu; Kou-Rong Miao; Ming Hong; Dan-Xia Zhu; Cheng Fang; Hua-Jie Dong; Dong-Mei Wang; Xin Cao; Jian-Yong Li

Book ID: 116430406
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 333 KB
Volume: 46
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2010.04.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose methylprednisolone can induce

High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities

✍ PatrickD. Thornton; Estella Matutes; AndrewG. Bosanquet; AnilK. Lakhani; Henri G 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 142 KB

Rituximab in combination with high-dose

Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia

✍ Castro, J E; Sandoval-Sus, J D; Bole, J; Rassenti, L; Kipps, T J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 159 KB

Low-dose oral fludarabine plus cyclophos

Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia

✍ Francesco Forconi; Alberto Fabbri; Mariapia Lenoci; Elisa Sozzi; Alessandro Gozz 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

## Abstract Fludarabine plus cyclophosphamide (FC) at conventional doses is an effective treatment for chronic lymphocytic leukaemia (CLL). However, FC at standard doses may give hematological and non‐hematological toxicity, predominantly in the elderly. Intravenous or oral low‐dose FC regimens rem

5.56 Ofatumumab in Combination with High

5.56 Ofatumumab in Combination with High-Dose Methylprednisolone as a Salvage Treatment for Heavily Pretreated or Refractory Patients with Chronic Lymphocytic Leukemia

✍ Juan S. Barajas-Gamboa; Julio A. Diaz-Perez; Lina M. Ariza-Serrano; John M. Hort 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 68 KB

Alemtuzumab in combination with high-dos

Alemtuzumab in combination with high-dose methylprednisolone is a logical, feasible and highly active therapeutic regimen in chronic lymphocytic leukaemia patients with p53 defects

✍ Pettitt, A R; Matutes, E; Oscier, D 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

Quercetin induced apoptosis in associati

Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients

✍ Russo, M; Spagnuolo, C; Volpe, S; Mupo, A; Tedesco, I; Russo, G-L 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 367 KB